TY  - GEN
AU  - Steger,Guenther G
AU  - Dominguez,Adriana
AU  - Dobrovolskaya,Natalia
AU  - Giotta,Francesco
AU  - Tubiana-Mathieu,Nicole
AU  - Pecherstorfer,Martin
AU  - Ardizzoia,Antonio
AU  - Blasinska-Morawiec,Maria
AU  - Espinosa,Enrique
AU  - Villanova,Gustavo
TI  - Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
SN  - 1938-0666
PY  - 2019///0319
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Hormonal
KW  - therapeutic use
KW  - Antineoplastic Agents, Phytogenic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Breast
KW  - pathology
KW  - Breast Neoplasms
KW  - Chemotherapy-Induced Febrile Neutropenia
KW  - epidemiology
KW  - Disease Progression
KW  - Fatigue
KW  - chemically induced
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Progression-Free Survival
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Receptors, Progesterone
KW  - Treatment Outcome
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clbc.2017.05.012
ER  -